CClinicalTrials.gg
CompletedNCT07601945Updated May 22, 2026

External Oblique Intercostal Fascial Plane Block Versus Rectus Sheath Block for Postoperative Analgesia

A Phase 3 interventional study of External Oblique Intercostal Fascial Plane Block for Postoperative Analgesia in External Oblique Intercostal Fascial Plane Block, Rectus Sheath Block and Pain, sponsored by Helwan University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Helwan University · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 11 months after the study started (first participant enrolled May 2023, registered Apr 2026).
Phase
Phase 3
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aimed to compare the analgesic efficacy of the external oblique intercostal fascial plane block (EOIPB) versus the rectus sheath block (RSB) for managing postoperative pain following paraumbilical hernioplasty.

Read the detailed description

Background: Paraumbilical hernia repair is a frequently performed surgical procedure, often associated with significant postoperative pain and delayed recovery, which are major concerns for patients.

Objectives: This study aimed to compare the analgesic efficacy of the external oblique intercostal fascial plane block (EOIPB) versus the rectus sheath block (RSB) for managing postoperative pain following paraumbilical hernioplasty.

Methods: This prospective, randomized, single-blinded study enrolled 60 patients, divided into two groups (EOIPB and RSB), each comprising 30 participants. Blocks were administered after general anesthesia and prior to surgery. Patient demographics (age, weight), surgical duration, pain scores (measured by Numeric Rating Scale - NRS), total postoperative morphine consumption, intraoperative fentanyl consumption, and hemodynamic parameters (mean arterial pressure - MAP and heart rate - HR) were assessed.

02

Conditions studied

  • External Oblique Intercostal Fascial Plane Block
  • Rectus Sheath Block
  • Pain

Browse trials for

Keywords

  • External Oblique Intercostal Fascial Plane Block
  • Rectus Sheath Block
  • Pain
03

In context

Pain

2,219 studies on the registry are indexed under Pain; 915 are open to participants now.

This study's enrollment of 30 is below the median of 70 across 1,901 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Helwan University is the lead sponsor of 69 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients aged 18-65 years, classified as American Society of Anesthesiologists (ASA) physical status I or II [16], and scheduled for elective paraumbilical hernioplasty.

Exclusion criteria

Exclusion Criteria:

  • Patients with a history of prolonged opioid medication, allergy to local anesthetics, pregnancy, infection at the injection site, and/or coagulopathy.
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    external oblique intercostal fascial plane block

    external oblique intercostal fascial plane block

    Procedure: External Oblique Intercostal Fascial Plane Block for Postoperative Analgesia

  • Active comparator
    rectus sheath block

    rectus sheath block

    Procedure: External Oblique Intercostal Fascial Plane Block for Postoperative Analgesia

Interventions

  • ProcedureExternal Oblique Intercostal Fascial Plane Block for Postoperative Analgesia

    After the induction of general anesthesia and approximately 15 minutes before the surgical incision, patients were randomly assigned to receive either the EOIPB (Group A) or the RSB (Group B).

06

What researchers measure

Primary outcomes

  1. Total postoperative morphine consumption in milligrams during the first 24 hours after surgery

    Total cumulative morphine requirement administered for postoperative analgesia during the first 24 hours following paraumbilical hernia repair surgery, measured in milligrams (mg).

    Time frame: First 24 hours postoperatively

  2. Number of participants experiencing block-related or postoperative complications within 3 months after surgery

    Assessment of postoperative and block-related complications including local anesthetic toxicity, hematoma, infection, nausea/vomiting, respiratory depression, and other adverse events recorded during the follow-up period.

    Time frame: 3 months after surgery

07

Study locations

1 site
  • Helwan university
    Giza, Giza Governorate 3030, Egypt
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07601945
Lead sponsor
Helwan University
Responsible party
Ahmed Abd Elmohsen Bedewy (Prof, Helwan University) — Principal investigator
First posted
May 22, 2026
Start date
May 1, 2023
Primary completion
Apr 30, 2025
Completion
Jun 30, 2025
Last update
May 22, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion